翻译前列腺癌的m6A表转录组

IF 12.1 1区医学 Q1 UROLOGY & NEPHROLOGY

Nature Reviews Urology Pub Date : 2025-06-09 DOI:10.1038/s41585-025-01054-2

Qian Tao, Qian Zhang

引用次数: 0

摘要

在前列腺癌中定位n6 -甲基腺苷（m6A）转录组已经确立了其作为前列腺癌预后生物标志物的临床潜在价值。整合基因组学、转录组学、表观转录组学、蛋白质组学和临床肿瘤学的多学科方法对于将m6A修饰的复杂性转化为患者的切实利益至关重要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Translating the m6A epitranscriptome for prostate cancer

查看原文本刊更多论文

Translating the m6A epitranscriptome for prostate cancer

Mapping the N6-methyladenosine (m6A) transcriptome in prostate cancer has established its clinical potential value as a prognostic biomarker for this disease. A multidisciplinary approach that integrates genomics, transcriptomics, epitranscriptomics, proteomics and clinical oncology is essential to translate the intricacies of m6A modification into tangible benefits for patients

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Urology 医学-泌尿学与肾脏学

CiteScore

12.50

自引率

2.60%

发文量

123

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Urology is part of the Nature Reviews portfolio of journals.Nature Reviews' basic, translational and clinical content is written by internationally renowned basic and clinical academics and researchers. This journal targeted readers in the biological and medical sciences, from the postgraduate level upwards, aiming to be accessible to professionals in any biological or medical discipline. The journal features authoritative In-depth Reviews providing up-to-date information on topics within a field's history and development. Perspectives, News & Views articles, and the Research Highlights section offer topical discussions and opinions, filtering primary research from various medical journals. Covering a wide range of subjects, including andrology, urologic oncology, and imaging, Nature Reviews provides valuable insights for practitioners, researchers, and academics within urology and related fields.